定量心肌灌注PET指导冠状动脉血运重建可提高 appropriateness
本研究纳入33例疑似或确诊冠心病并转诊冠状动脉造影的患者,在造影前用13N-NH3 PET定量心肌灌注,造影医师对PET结果设盲。结果显示,PCI前区域心肌血流储备(MFR)正常的血管区域在PCI后未见改善,而基线MFR<2.0的区域PCI后显著改善;作者认为血运重建前定量心肌灌注评估可促进冠状动脉造影的更合理使用。
要点
- PCI前区域MFR正常的血管区域,PCI后MFR未见改善(P=0.9)。
- 基线区域MFR<2.0的血管区域,PCI后MFR显著改善(P=0.003)。
- 血运重建前定量心肌灌注评估可能促进稳定冠心病患者冠状动脉造影的更合理使用。
核心结论
- 血运重建前定量评估心肌灌注可促进稳定冠心病患者冠状动脉造影的更合理使用。
研究设计与样本
- 纳入33例(女性10例)疑似或确诊冠心病并转诊临床冠状动脉造影且可能行PCI的患者。
- 在冠状动脉造影前4±3周及造影后5±1个月行腺苷负荷与静息13N-NH3 PET、心脏磁共振(CMR)及心肺运动试验。
- 造影医师对PET和CMR结果设盲,PET测得心肌血流储备(MFR)<2.0定义为异常。
主要发现
- 33例中19例行PCI。
- 在41%(11/27)的血运重建血管区域中,PCI前区域MFR正常,随访时MFR未见改善(P=0.9)。
- 基线区域MFR<2.0的血管区域在PCI后显著改善(P=0.003)。
- 未行PCI的14例患者中,4例在一个或多个冠状动脉区域MFR<2.0。
关键数值与推荐
- PET测得心肌血流储备(MFR)<2.0定义为异常。
- PCI前区域MFR正常的血管区域PCI后MFR未见改善(P=0.9)。
- 基线区域MFR<2.0的血管区域PCI后MFR显著改善(P=0.003)。
临床怎么用
- 对稳定冠心病患者在血运重建决策前可行定量心肌灌注PET评估,以辅助判断哪些血管区域可能从PCI获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients undergo percutaneous coronary intervention (PCI) without the use of non-invasive stress testing prior to treatment. The aim of this study was to determine the potential added value of guiding revascularization by quantitative assessment of myocardial perfusion prior to intervention. METHODS AND RESULTS: Thirty-three patients (10 females) with suspected or established CAD who had been referred for a clinical coronary angiography (CA) with possibility for PCI were included. Adenosine stress and rest 13N-NH3 PET, cardiac magnetic resonance (CMR), and cardiopulmonary exercise test were performed 4 ± 3 weeks before and 5 ± 1 months after CA. The angiographer was blinded to the PET and CMR results. Myocardial flow reserve (MFR) < 2.0 by PET was considered abnormal. A PCI was performed in 19/33 patients. In 41% (11/27) of the revascularized vessel territories, a normal regional MFR was found prior to the PCI and no improvement in MFR was found at follow-up (P = 0.9). However, vessel territories with regional MFR < 2.0 at baseline improved significantly after PCI (P = 0.003). Of the 14 patients not undergoing PCI, four had MFR < 2.0 in one or more coronary territories. CONCLUSION: Assessment of quantitative myocardial perfusion prior to revascularization could lead to more appropriate use of CA when managing patients with stable CAD.
引用
- Akil S, Hedeer F, Oddstig J, et al. Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decision. J Nucl Cardiol. 2019. PMID: 31705424. doi:10.1007/s12350-019-01938-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。